A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Status

NO_LONGER_AVAILABLE

Phases

Unknown

Study type

Expanded Access

Source

ClinicalTrials.gov

Registry ID

NCT00801515

Enrollment

Unknown

Registered

2008-12-03

Start date

2009-08-31

Completion date

2011-07-31

Last updated

2011-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

Compassionate, HIV, CCR5

Brief summary

This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of maraviroc when added to OBT will be continued.

Interventions

DRUGMaraviroc

150 mg twice per day

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients having completed study A4001029 in Canada and still deriving clinical benefit.

Exclusion criteria

* None

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026